Brokers Set Expectations for Bovie Medical Co.’s FY2018 Earnings (BVX)

Bovie Medical Co. (NYSEAMERICAN:BVX) – Piper Jaffray reduced their FY2018 EPS estimates for Bovie Medical in a research report issued to clients and investors on Monday, May 14th. Piper Jaffray analyst M. O’brien now anticipates that the medical device company will earn ($0.02) per share for the year, down from their previous estimate of ($0.01).

Bovie Medical (NYSEAMERICAN:BVX) last issued its earnings results on Monday, March 12th. The medical device company reported ($0.03) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.02) by ($0.01). The business had revenue of $11.35 million for the quarter, compared to analyst estimates of $10.37 million. Bovie Medical had a negative return on equity of 21.67% and a negative net margin of 13.32%.

BVX has been the subject of several other research reports. Zacks Investment Research downgraded Bovie Medical from a “hold” rating to a “sell” rating in a research note on Friday, February 9th. TheStreet raised Bovie Medical from a “d” rating to a “c-” rating in a research note on Monday.

Shares of NYSEAMERICAN BVX opened at $4.08 on Thursday. Bovie Medical has a 12 month low of $3.95 and a 12 month high of $3.99.

Large investors have recently added to or reduced their stakes in the company. Salem Investment Counselors Inc. grew its holdings in shares of Bovie Medical by 104.1% during the fourth quarter. Salem Investment Counselors Inc. now owns 60,757 shares of the medical device company’s stock worth $158,000 after purchasing an additional 30,986 shares during the last quarter. Raymond James & Associates bought a new stake in shares of Bovie Medical during the fourth quarter worth about $307,000. James Hambro & Partners bought a new stake in shares of Bovie Medical during the fourth quarter worth about $416,000. White Pine Capital LLC bought a new stake in shares of Bovie Medical during the fourth quarter worth about $659,000. Finally, Cowen Prime Services LLC grew its holdings in shares of Bovie Medical by 69.4% during the fourth quarter. Cowen Prime Services LLC now owns 295,041 shares of the medical device company’s stock worth $767,000 after purchasing an additional 120,871 shares during the last quarter.

Bovie Medical Company Profile

Bovie Medical Corporation, a medical device company, develops, manufactures, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue.

Receive News & Ratings for Bovie Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit